Atrium-Selective Sodium Channel Block as a Strategy for Suppression of Atrial Fibrillation
Top Cited Papers
Open Access
- 25 September 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 116 (13) , 1449-1457
- https://doi.org/10.1161/circulationaha.107.704890
Abstract
Background— The development of selective atrial antiarrhythmic agents is a current strategy for suppression of atrial fibrillation (AF). Methods and Results— Whole-cell patch clamp techniques were used to evaluate inactivation of peak sodium channel current (INa) in myocytes isolated from canine atria and ventricles. The electrophysiological effects of therapeutic concentrations of ranolazine (1 to 10 μmol/L) and lidocaine (2.1 to 21 μmol/L) were evaluated in canine isolated coronary-perfused atrial and ventricular preparations. Half-inactivation voltage of INa was ≈15 mV more negative in atrial versus ventricular cells under control conditions; this difference increased after exposure to ranolazine. Ranolazine produced a marked use-dependent depression of sodium channel parameters, including the maximum rate of rise of the action potential upstroke, conduction velocity, and diastolic threshold of excitation, and induced postrepolarization refractoriness in atria but not in ventricles. Lidocaine also pref...Keywords
This publication has 28 references indexed in Scilit:
- Ranolazine Improves Abnormal Repolarization and Contraction in Left Ventricular Myocytes of Dogs with Heart Failure by Inhibiting Late Sodium CurrentJournal of Cardiovascular Electrophysiology, 2006
- Role of Repolarization Restitution in the Development of Coarse and Fine Atrial Fibrillation in the Isolated Canine Right AtriaJournal of Cardiovascular Electrophysiology, 2005
- Radiofrequency ablation of Mahaim pathway during atrial fibrillationHeart Rhythm, 2005
- AZD7009:Journal of Cardiovascular Electrophysiology, 2004
- Electrophysiologic Properties and Antiarrhythmic Actions of a Novel Antianginal AgentJournal of Cardiovascular Pharmacology and Therapeutics, 2004
- The sodium channel beta-subunit SCN3b modulates the kinetics of SCN5a and is expressed heterogeneously in sheep heartThe Journal of Physiology, 2001
- The M Cell:Journal of Cardiovascular Electrophysiology, 1999
- Effects of WAY-123,398, a New Class III Antiarrhythmic Agent, on Cardiac Refractoriness and Ventricular Fibrillation Threshold in Anesthetized Dogs: A Comparison with UK-68798, E-4031, and dl-SotalolJournal of Cardiovascular Pharmacology, 1992
- Comparative Analysis of the Action of Class I Antiarrhythmic Drugs (Lidocaine, Quinidine, and Prajmaline) in Rabbit Atrial and Ventricular MyocardiumJournal of Cardiovascular Pharmacology, 1990
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989